Articles

Videos

Podcasts

Clinical

Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.

Pharmacy Clinical Pearl of the Day: Non-alcoholic Steatohepatitis 

A huge cost savings could be generated with the success of a hepatitis C vaccine.

Vaccine to Protect Against Hepatitis C May Be Available in Next 5 Years

According to the US Department of Health and Human Services Office of Minority Health, Asian Americans are 40% more likely to be diagnosed with diabetes and 60% more likely to be diagnosed with renal disease compared to non-Hispanic whites.

How Pharmacists Can Help Address Health Disparities Among Asian Americans

The finding raises the potential for repurposing available drugs as COVID-19 antivirals for cases in which a vaccine is not practical or effective, according to RPI chemistry and chemical professor Gaetano Montelione.

New Findings Suggest Hepatitis C Drugs May Multiply Effect of COVID-19 Antiviral Remdesivir

Patient and provider organizations urge the Department of Health and Human Services and the Biden administration to enact policies and protections that improve prescription drug affordability for people in the United States.

More Than 100 Patient Groups Advocate for Affordable Prescription Drugs

Bariatric surgery can significantly reduce the risk of cancer—and especially obesity-related cancers—by as much as half in individuals with severe obesity and nonalcoholic fatty liver disease (NAFLD), according to a study by researchers at Rutgers Robert Wood Johnson Medical School's Center for Liver Diseases and Liver Masses.

Study: Bariatric Surgery Reduces Cancer Risk for Patients With NAFLD

Pharmacists can learn how to adequately inform patients about therapeutic options that are available as a method to improve access to care.
 

Treat Hepatitis C Through a Medical Education Program

According to Senhwa Biosciences, the study’s findings indicate a clinically meaningful improvement in progression-free survival (PFS) (P

Cholangiocarcinoma Therapy Trial Demonstrates Promising Results in Study

The study was done in an effort to help quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases, according to the study authors.

X-ray Study Explores Potential of Hepatitis C Drugs to Treat COVID-19

Researchers have identified the role of a protein involved in the progression of hepatitis C virus (HCV) infection that has demonstrated a potential new avenue for treatment.
 